|
Sep 23, 2009, this day is
written into China's pharmaceutical industry history! On
this day, the top 10 world pharmaceutical companies,
officials from FDA, EMEA and SFDA, DBA, top pharmaceutical
engineering media, numerous domestic engineering companies
and elites from major pharmaceutical companies around the
world will gather in Tianjin, China to get a deep
appreciation of Pharmaceutical Engineering! This is a rare
opportunity for elites based in China pharmaceutical
industry, as well as a heaven-sent opportunity to combine
engineering services with users.
2004 witnessed the end of the
first round of GMP certification in Chinese pharmaceutical
industry and the reduction of the number of pharmaceutical
producing enterprises from 6,000 to 4,000. New version of
GMP was again listed on the agenda after five years. With
further efforts in being compatible with European and U.S
cGMP such as EMEA and FDA, new version of GMP becomes more
stringent. Integration, merge and acquisition of Chinese
pharmaceutical industry are imperative under such a
circumstance. Only preparations are made in advance can help
to take the preemptive opportunities, however
★ How to crack hard issues in
the transformation of old projects after adjustments in
product variety?
★ How to satisfy the needs of
expanding the production capacity of the original plants
after enterprise merge and acquisition?
★ How to efficiently perform
the design, construction, management and operation of new
large-scale projects?
★ How to avoid the problems
concerning non-conforming design, construction and process
of conventional project model?
★ How to satisfy new
requirements of new version of GMP for facilities, equipment
and process certification?
★ How to deal with the
pressure from continuously increasing costs in raw
materials, operation and human resources on a global scale?
Pharmaceutical quality management system with
the philosophy of Quality by Design (QbD) as the core and
best-performing EPC (Engineering、Procurement、Construction)
general contractor mode widely adopted in foreign counties
will serve as the fundamental way to address these issues.
2009 International Forum of Pharmaceutical Engineering and
Generic Drug R&D to be held during September 23 and
September 24, 2009 will create one platform for information
exchange.
Here, you can see
★ Multi-dimensional
decipherment of European and U.S's latest laws and
regulations of drugs production and supervision.
★ Full-range flashback of
successful cases of global pharmaceutical engineering
projects.
★ Analysis of the whole
process of pharmaceutical quality assurance of international
large pharmaceutical enterprises.
Besides FDA and SFDA
officials, speakers from many international famous
pharmaceutical engineering enterprises such as M+W Zander,
JGC, Foster Wheeler, PM Group, NNE Pharmaplan, BTES and VTI
will also attend this Forum to offer classical project cases
to the audience.
Additionally, patent drug
has peaked in terms of the expiration in the world's
pharmaceutical manufacturing history since 2007, which means
golden opportunity for Chinese pharmaceutical enterprises
specializing in generic drug to go globally. Generic Drug
Research and Development Sub-forum will be concurrently held
during the period of this Forum to explore a scientific and
rational way of researching and developing generic drug and
analyze new opportunities for Chinese pharmaceutical
industry.
|
